GB2059770A - Treatment of glaucoma - Google Patents

Treatment of glaucoma Download PDF

Info

Publication number
GB2059770A
GB2059770A GB8031420A GB8031420A GB2059770A GB 2059770 A GB2059770 A GB 2059770A GB 8031420 A GB8031420 A GB 8031420A GB 8031420 A GB8031420 A GB 8031420A GB 2059770 A GB2059770 A GB 2059770A
Authority
GB
United Kingdom
Prior art keywords
composition
salt
atherapeutic
phenyl
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8031420A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of GB2059770A publication Critical patent/GB2059770A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB8031420A 1979-10-01 1980-09-29 Treatment of glaucoma Withdrawn GB2059770A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8039379A 1979-10-01 1979-10-01

Publications (1)

Publication Number Publication Date
GB2059770A true GB2059770A (en) 1981-04-29

Family

ID=22157087

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8031420A Withdrawn GB2059770A (en) 1979-10-01 1980-09-29 Treatment of glaucoma

Country Status (15)

Country Link
JP (1) JPS5651413A (fr)
AR (1) AR224030A1 (fr)
AU (1) AU6286980A (fr)
BE (1) BE885496A (fr)
DE (1) DE3037164A1 (fr)
DK (1) DK413280A (fr)
ES (1) ES8203223A1 (fr)
FI (1) FI803123L (fr)
FR (1) FR2466249A1 (fr)
GB (1) GB2059770A (fr)
IT (1) IT1133829B (fr)
LU (1) LU82816A1 (fr)
NO (1) NO802890L (fr)
SE (1) SE8006844L (fr)
ZA (1) ZA806085B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021629A2 (fr) 2010-08-11 2012-02-16 Philadelphia Health & Education Corporation Nouveaux agonistes du récepteur dopaminergique d3 pour traiter la dyskinésie dans la maladie de parkinson

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021629A2 (fr) 2010-08-11 2012-02-16 Philadelphia Health & Education Corporation Nouveaux agonistes du récepteur dopaminergique d3 pour traiter la dyskinésie dans la maladie de parkinson
EP2603215A4 (fr) * 2010-08-11 2015-08-05 Philadelphia Health & Educatio Nouveaux agonistes du recepteur dopaminergique d3 pour traiter la dyskinesie dans la maladie de parkinson
US10543180B2 (en) 2010-08-11 2020-01-28 Drexel University D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease
US11266612B2 (en) 2010-08-11 2022-03-08 Drexel University D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease

Also Published As

Publication number Publication date
NO802890L (no) 1981-04-02
ES496072A0 (es) 1982-04-01
IT8025066A0 (it) 1980-10-01
FR2466249A1 (fr) 1981-04-10
ES8203223A1 (es) 1982-04-01
DE3037164A1 (de) 1981-04-16
AU6286980A (en) 1981-04-09
IT1133829B (it) 1986-07-24
SE8006844L (sv) 1981-04-02
AR224030A1 (es) 1981-10-15
BE885496A (fr) 1981-04-01
DK413280A (da) 1981-04-02
JPS5651413A (en) 1981-05-09
FI803123L (fi) 1981-04-02
LU82816A1 (fr) 1981-04-17
ZA806085B (en) 1981-09-30

Similar Documents

Publication Publication Date Title
US4599353A (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4454151A (en) Use of pyrrolo pyrroles in treatment of ophthalmic diseases
EP0326915B1 (fr) Composition thérapeutique à usage local pour traiter les maladies inflammatoires
KR950004885B1 (ko) 아세틸 d-카르니틴을 함유하는 녹내장 치료제
US4599360A (en) Ophthalmic anti-inflammatory agents
US5290781A (en) Ketaneserinol as an agent to reduce intraocular pressure
JP3488456B2 (ja) 眼圧降下剤としての２−デカルボキシル−２−アミノアルキル−プロスタグランジン
US5288735A (en) Treatment of glaucoma
US5998467A (en) Medicine for oculopathy
US5686450A (en) Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
US5066664A (en) 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents
AU616748B2 (en) Ophthalmic solution for intraocular pressure adjustment
US4766151A (en) Ethers and oxime ethers of alkylamino alcohols as medicaments and novel products, and processes for their preparation
AU668024B2 (en) Agent for prophylaxis or treatment of cataract
CA2065965C (fr) Compositions ophtalmiques comprenant un inhibiteur de l'anhydrase carbonique et un antagoniste des recepteurs beta-adrenergiques
EP0499882A1 (fr) Compositions pharmaceutiques contenant des dérivés de la N-acétyl-cysteine pour le traitement de la cataracte
US5565434A (en) Hexose and pentose prodrugs of ethacrynic acid
JPH06316519A (ja) 薬剤で誘導される瞳孔拡大を抑制し又は拡大された瞳孔を 縮小するための、一定のスルファモイル置換フェネチルア ミン誘導体の使用、及びそれに用いる局部的投与組成物
GB2059770A (en) Treatment of glaucoma
EP0420606B1 (fr) Utilisation de 2-cycloalkylamino oxazolines pour réduire ou maintenir la pression intraoculaire
US3991206A (en) Alleviation of eye inflammation by topical application of p-biphenylacetic acid
US4590210A (en) Compositions for treatment of ocular hypertension
JPH02258751A (ja) ３，４―ジヒドロキシベンゾイルオキシプロパノールアミン類のプロドラッグ
US5225424A (en) Methazolamide-derived carbonic anhydrase inhibitors
US4705798A (en) Phenylephrine prodrug useful as mydriatic agent

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)